Loading...
Derniers dépôts
-
Karima El Alaoui-Lasmaili, El-Hadi Djermoune, Jean-Baptiste Tylcz, Dominique Meng, François Plénat, et al.. A new algorithm for a better characterization and timing of the anti-VEGF vascular effect named “normalization”. Angiogenesis, 2017, 20 (1), pp.149-162. ⟨10.1007/s10456-016-9536-3⟩. ⟨hal-01416154⟩
-
Mario Campone, Thomas Bachelot, Isabelle Treilleux, Barbara Pistilli, Julia Salleron, et al.. A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial). European Journal of Cancer, 2021, 158, pp.169-180. ⟨10.1016/j.ejca.2021.09.017⟩. ⟨hal-03469622⟩
-
Margaux Betz, Vincent Massard, Pauline Gilson, Andréa Witz, Julie Dardare, et al.. ESR1 gene mutations and liquid biopsy in ER-positive breast cancers: A small step forward, a giant leap for personalization of endocrine therapy?. Cancers, 2023, 15 (21), pp.5169. ⟨10.3390/cancers15215169⟩. ⟨hal-04295094⟩
-
Marie-Alphée Laurent, Pauline Audurier, Vanessa de Castro, Xiaoqing Gao, Jean-Baptiste Durand, et al.. Towards an optimization of functional localizers in non-human primate neuroimaging with (fMRI) frequency-tagging. NeuroImage, 2023, 270, pp.119959. ⟨10.1016/j.neuroimage.2023.119959⟩. ⟨hal-04274554⟩
-
Julie Egea, Julia Salleron, Sophie Gourgou, Ahmet Ayav, Valérie Laurent, et al.. Development of a clinical-biological model to assess tumor progression in metastatic pancreatic cancer: Post hoc analysis of the PRODIGE4/ACCORD11 trial. Cancers, 2022, 14 (20), pp.5068. ⟨10.3390/cancers14205068⟩. ⟨hal-03901662⟩